ro 5-4864 has been researched along with Alloxan Diabetes in 2 studies
4'-chlorodiazepam: selectively binds peripheral benzodiazepine receptor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Z | 1 |
| Han, Y | 1 |
| Wu, L | 1 |
| Xia, T | 1 |
| Ren, H | 1 |
| Yang, D | 1 |
| Gu, D | 1 |
| Wang, H | 1 |
| Hu, C | 1 |
| He, D | 1 |
| Zhou, L | 1 |
| Zeng, C | 1 |
| Giatti, S | 1 |
| Pesaresi, M | 1 |
| Cavaletti, G | 1 |
| Bianchi, R | 1 |
| Carozzi, V | 1 |
| Lombardi, R | 1 |
| Maschi, O | 1 |
| Lauria, G | 1 |
| Garcia-Segura, LM | 1 |
| Caruso, D | 1 |
| Melcangi, RC | 1 |
2 other studies available for ro 5-4864 and Alloxan Diabetes
| Article | Year |
|---|---|
Translocator protein 18 kDa ligand alleviates neointimal hyperplasia in the diabetic rat artery injury model via activating PKG.
Topics: Animals; Benzodiazepinones; Carotid Arteries; Carrier Proteins; Cell Movement; Cell Proliferation; C | 2019 |
Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy.
Topics: Animals; Benzodiazepinones; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetic Neuropathies | 2009 |